Detailed Information
Cited 2 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Safety and anti-tumor activity of the transforming growth factor beta receptor I kinase inhibitor, vactosertib, in combination with pembrolizumab in patients with metastatic colorectal or gastric cancer
- Authors
- Lee, KW[Lee, Keun-Wook]; Park, YS[Park, Young Suk]; Ahn, JB[Ahn, Joong Bae]; Rha, SY[Rha, Sun Young]; Kim, HK[Kim, Hark Kyun]; Lee, PY[Lee, Park Young]; Ryu, MH[Ryu, Min-Hee]; Lee, J[Lee, Jeeyun]; Lee, JK[Lee, Jin Kyung]; Hwang, S[Hwang, Sunjin]; Kiim, SJ[Kiim, Seong-Jin]; Kim, TW[Kim, Tae Won]
- Issue Date
- 6-Nov-2019
- Publisher
- BMC
- Citation
- JOURNAL FOR IMMUNOTHERAPY OF CANCER, v.7
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL FOR IMMUNOTHERAPY OF CANCER
- Volume
- 7
- ISSN
- 2051-1426
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.